"I would be very curious to hear an estimate of when the FA might be if calculated at 75% of events.  I haven't seen such an estimate from anyone thus far."

I did answer you a few days ago in this post. And I will re-iterate....not knowing whether or not we've already hit 125 events (50% of 250 event target) really makes it difficult to project when we may hit 75% of the 250 event target. 

However, based on my previous estimates based on the EXAMINE trial population, an overall increase in event rate due to the additional low-HDL requirement, and the 30% RRR in the apabetalone arm......I originally projected hitting 125 events by end of Sept 2017. If that is true and we've already hit 125 events......then if I gaze into the crystal ball for 75% of events (187.5 events), I see us reaching that number by the end of Q1 2018. If we haven't hit 125 events yet, then I don't see us hitting 75% of events until closer to mid-2018. But like I said, too many unknowns to trust the crystal ball too much. 

BearDownAZ